Schwartz J L, Murnane J, Weichselbaum R R
Department of Radiation Oncology, University of Washington, Seattle, WA 98195, USA.
Br J Cancer. 1999 Feb;79(5-6):744-7. doi: 10.1038/sj.bjc.6690119.
The contribution of DNA ploidy to radiation sensitivity was investigated in a group of eight human tumour cell lines. As previous studies suggest, while more aneuploid tumours tend to be more radioresistant, there is no significant relationship between ploidy and radiation sensitivity (SF2). The failure to observe a significant effect of ploidy on radiation sensitivity is due to the complex and multifactorial basis of radiation sensitivity. When we determined the relationship between survival and radiation-induced chromosome aberration frequency, a measure independent of most other modifiers of sensitivity, we observed a direct relationship between ploidy and mean lethal aberration frequency. The mean lethal frequency of aberrations increased from about 1 for diploid cells to about 2 for tetraploid cells. The mean lethal frequency of aberrations was independent of DNA repair variations. These observations demonstrate that changes in DNA ploidy are an important contributor to radiation sensitivity variations in human tumour cell lines. Therefore, any battery of predictive assays should include DNA ploidy measurements.
在一组8种人类肿瘤细胞系中研究了DNA倍性对辐射敏感性的影响。如先前研究所示,虽然更多非整倍体肿瘤往往更具放射抗性,但倍性与辐射敏感性(SF2)之间没有显著关系。未能观察到倍性对辐射敏感性有显著影响是由于辐射敏感性的复杂多因素基础。当我们确定存活与辐射诱导的染色体畸变频率之间的关系时(这是一种独立于大多数其他敏感性修饰因子的指标),我们观察到倍性与平均致死畸变频率之间存在直接关系。畸变的平均致死频率从二倍体细胞的约1增加到四倍体细胞的约2。畸变的平均致死频率与DNA修复变异无关。这些观察结果表明,DNA倍性的变化是人类肿瘤细胞系中辐射敏感性变化的重要因素。因此,任何一组预测性检测都应包括DNA倍性测量。